92 completed, 13 unknown, 7 terminated, 6 active not recruiting. 59 Phase 1, 28 Phase 4, 11 Phase 3, 10 Phase 2, 8 Not applicable.
Follow Carbamazepine: new trials by email Literature Review of Carbamazepine trials Research Report on Carbamazepine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Verducatib in the Blood Verducatib, Carbamazepine - Healthy | Phase 1 | Recruiting | Boehringer Ingelheim | 20 | 2026-09-10 | 2026-09-23 |
| Clinical Efficacy and Peripheral Ultrasound Mechanism of Trigger Point Bloodletting Therapy for Primary Trigeminal Neuralgia Trigger Point Bloodletting Therapy, Carbamazepine - Trigeminal Neuralgia (TN) | Not applicable | Not yet recruiting | Beijing Hospital of Traditional Chinese Medicine | 60 | 2026-08-31 | 2026-08-06 |
| A Trial of Lu AH69593 in Healthy Participants Lu AH69593, Itraconazole, Carbamazepine - Healthy Participants | Phase 1 | Recruiting | H. Lundbeck A/S | 46 | 2026-08-27 | 2026-10-14 |
| A Study to Evaluate the Effect of Carbamazepine or Itraconazole on Radiprodil in Healthy Adult Participants Radiprodil, Carbamazepine, Itraconazole (200 mg) - Healthy Adult Participants | Phase 1 | Active not recruiting | GRIN Therapeutics, Inc. | 36 | 2026-06-08 | 2026-10-21 |
| Drug-Drug Interaction Study of Atumelnant in Healthy Participants Atumelnant, Carbamazepine, Midazolam - Healthy Volunteers | Phase 1 | Completed | Crinetics Pharmaceuticals Inc. | 46 | 2026-05-28 | 2026-08-19 |
| Drug-drug Interaction Trial of AP31969 and Carbamazepine or Itraconazole AP31969, Carbamazepine, Itraconazole - Healthy Participants | Phase 1 | Completed | Acesion Pharma | 28 | 2026-04-01 | 2026-05-22 |
| A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together Repinatrabit, EE/NE, Metformin - Healthy Volunteers | Phase 1 | Recruiting | Otsuka Pharmaceutical Development & Commercialization, Inc. | 48 | 2026-03-31 | 2026-08-12 |
| A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body Processes ASP3082 in Healthy Adults Setidegrasib, Fluconazole, Carbamazepine - Healthy Volunteer | Phase 1 | Active not recruiting | Astellas Pharma Global Development, Inc. | 54 | 2026-02-03 | 2026-08-27 |
| To Assess the Enzyme Inducing Effects of Carbamazepine on the PK of Mirdametinib in Healthy Participants Mirdametinib, Mirdametinib and Carbamazepine - Healthy, Volunteer | Phase 1 | Completed | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 36 | 2025-12-15 | 2026-05-08 |
| A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144 PF-07248144, Carbamazepine - Healthy Adults | Phase 1 | Completed | Pfizer | 12 | 2025-09-18 | 2026-04-03 |
| A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Nerandomilast in the Blood nerandomilast, carbamazepine - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 16 | 2025-08-11 | 2025-10-14 |
| Comparison b/w Carbamazepine vs Oxcarbazepine in Treatment of Trigeminal Neuralgia Carbamazepine, oxcarbazepine - Trigeminal Neuralgia | Not applicable | Active not recruiting | Abbasi Shaheed Hospital | 122 | 2025-05-20 | 2025-11-26 |
| Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults Radiprodil with Carbamazepine, Radiprodil with Itraconazole - Tuberous Sclerosis Complex (TSC), Focal Cortical Dysplasia | Phase 1 | Terminated | GRIN Therapeutics, Inc. | 30 | 2025-05-08 | 2025-11-21 |
| A Study to Evaluate the Effect of Food on the Single-Dose Pharmacokinetics and a Drug-Drug Interaction Evaluation of Itraconazole and Carbamazepine on INCB123667 When Administered Orally to Healthy Adult Participants INCB123667, itraconazole, carbamazepine - Healthy Participants | Phase 1 | Completed | Incyte Corporation | 51 | 2025-05-05 | 2026-06-15 |
| Drug-Drug Interaction Potential of Mavorixafor Mavorixafor, Carbamazepine, Efavirenz - Healthy Participants | Phase 1 | Completed | X4 Pharmaceuticals | 38 | 2025-02-18 | 2025-07-01 |
| A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323. EDP-323, Itraconazole, carbamazepine - RSV Infection, Drug Drug Interaction (DDI) | Phase 1 | Completed | Enanta Pharmaceuticals, Inc | 48 | 2025-01-27 | 2025-07-01 |
| A Multi-part Study of ALG-000184 to Evaluate Safety, Tolerability, Pharmacokinetics and Drug-drug Interaction Potential After Single and Multiple Doses in Healthy Volunteers Carbamazepine, Itraconazole (Sporanox), ALG-000184 - Healthy Volunteer | Phase 1 | Active not recruiting | Aligos Therapeutics | 24 | 2025-01-09 | 2025-02-03 |
| A Drug-Drug Interaction Study of Carbamazepine and Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-012) Opevesostat, Prednisone, Fludrocortisone acetate - Healthy | Phase 1 | Completed | Merck Sharp & Dohme LLC | 14 | 2024-12-18 | 2025-05-25 |
| A Drug-drug Interaction Study of S-892216 Coadministered With Carbamazepime to Healthy Adult Participants S-892216, Carbamazepine - COVID-19 | Phase 1 | Completed | Shionogi | 16 | 2024-12-17 | 2025-03-11 |
| Drug-Drug Interaction Study of Bomedemstat and Carbamazepine in Healthy Adult Participants (MK-3543-020) bomedemstat, carbamazepine - Healthy | Phase 1 | Completed | Merck Sharp & Dohme LLC | 16 | 2024-10-02 | 2025-03-18 |
Showing 20 of 122. Sign in to see all of them.
Epilepsy (25) · Seizures (9) · Bipolar Disorder (8) · Trigeminal Neuralgia (7) · Cocaine-Related Disorders (4) · Substance-Related Disorders (4) · COVID-19 (3) · Epilepsies, Partial (3) · Asthma (2) · Epilepsy, Rolandic (2) · Mania (2) · Neuralgia (2) · Schizophrenia (2) · Aggression (1) · Alcoholism (1)
Eli Lilly and Company (6) · Boehringer Ingelheim (4) · Cerevel Therapeutics, LLC (3) · Enanta Pharmaceuticals, Inc (3) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (3) · Pfizer (3) · Alexion Pharmaceuticals, Inc. (2) · Aligos Therapeutics (2) · AstraZeneca (2) · Bayer (2) · Centre of Chinese Medicine, Georgia (2) · DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company (2) · Dizal Pharmaceuticals (2) · Eisai Inc. (2) · GRIN Therapeutics, Inc. (2)
United States (53) · Germany (11) · United Kingdom (8) · Australia (5) · France (5) · India (5) · Italy (5) · South Korea (5) · Belgium (4) · Canada (3) · Greece (3) · Hungary (3) · Russia (3) · Taiwan (3) · Bangladesh (2)
Manana Tchaia, MD (2) · Merab Lomia, MD, PhD (2) · William Haning, M.D. (2) · Ahmed F El-Yazbi, PhD (1) · Andrew G Herzog, MD (1) · Aymen H Hamouri, MSc (1)
PMID 25912051, PMID 10431771, PMID 10908900, PMID 11207795, PMID 12428025, PMID 15072107, PMID 15380560, PMID 16597501, PMID 17145735, PMID 1744641, PMID 18245032, PMID 18595663, PMID 20573223, PMID 21621166, PMID 22134145, PMID 22417223, PMID 22683226, PMID 23664631, PMID 25684224, PMID 27517350, PMID 28446244, PMID 28832750, PMID 28901625, PMID 29028517, PMID 29920885, PMID 30986735, PMID 31237566, PMID 31651956, PMID 31655626, PMID 31744781, PMID 33249870, PMID 33434956, PMID 33688834, PMID 34930487, PMID 35129214, PMID 37609651, PMID 40679917, PMID 41703907, PMID 6317805, PMID 7044473, PMID 7783877, PMID 8635421, PMID 9578017, PMID 9595992, PMID 9812178
2025 (2), 2008 (1), 2018 (1), 2019 (1), 2023 (1), R01DA012268 (1), R01MH078060 (1), R18DA006954 (1), R21DK092567 (1), R29DA007761 (1)